Overview

"Easily the best firm to work with in the field... An unmatched leader across the board."

The Legal 500 United States 2018, Client Reference

Today’s global healthcare marketplace is marked by unprecedented transformation and opportunity. Healthcare delivery and reimbursement is shifting toward value-based care and vertical consolidation at a rapid pace, as systems, health plans and other forward-thinking leaders join forces to tackle some of the industry’s biggest challenges. Digital health solutions are evolving the doctor-patient relationship beyond the in-person encounter—fundamentally transforming the quality and delivery of healthcare. And investors are taking notice.

If you’re doing something that’s never been done before, or looking to do something better than it’s ever been done before, we’re here to help.

We collaborate with those at the forefront of health industry innovation to foster the unique partnerships and business ventures that are transforming healthcare.

Exclusively serving the health industry, our policy and lobbying team, McDermottPlus, uses data-driven insights, experience and analytics to tackle challenges, identify alternatives, and implement strategies when clients are faced with legislative and regulatory obstacles that challenge their market objectives, business operations and opportunities.

A Decade at the Top

McDermott again awarded the nation’s only Band 1 healthcare firm by Chambers USA

Healthcare Partnerships that Work

Collaborative Transformation

Let's Get to Work

Named "Health Group of the Year 2018"

Law360

McDermott's Healthcare Speakers Bureau

Customizable, In-Person Programming from the Leading Healthcare Law Firm

Learn More

Results

The Permanente Federation in structuring a pilot program to develop primary care walk-in clinics in Target Stores to provide medical care to Kaiser Permanente members and to other Target customers
23andMe in completing a transaction for access to the client’s database of whole genetic sequences for the study of potential genetic targets for Parkinson’s Disease
MTS Health Investors in connection with the acquisition of a majority stake in a clinical research organization specializing in early stage clinical trials with global operations in the
United States, Canada, Switzerland, Ireland, South Korea and Singapore

Healthcare